TEL：
Main products: Intermediate of Umeclidinium bromide,Vilanterol Trifenate,Empagliflozin.
ABOUT US
HSDK（Nanjing）Pharma Tech Co.，Ltd. was established in 2020. The company is located in the R&D Center of Nanjing Chemical Industry Park, a National Chemical Park. It is a high-tech company integrating R&D, manufacturing and sales of pharmaceutical intermediates and fine chemicals. The technology enterprise with a registered capital of CNY 10 million.
HSDK（Nanjing）Pharma Tech Co.，Ltd. has a high-level R&D and manufacturing environment, which includes the R&D center, quality control center, pilot scale laboratory and manufacturing base (Fujian Welike Pharma Co.，Ltd). The company's R&D team is composed of overseas PhDs, senior engineers, doctors, masters and undergraduates, most of whom have worked in listed pharmaceutical companies for many years.
The company takes "creating leading drug development and production and sincere outsourcing services" as its development purpose and belief, in line with the enterprise spirit of "pragmatism and innovation", adhering to the business philosophy of "technical innovation, sharing and win-win". HSDK（Nanjing）Pharma Tech, with a rigorous attitude, strives to develop and produce market-oriented quality products.
CONTACT US
TELPHONE：025-52440010
WEBISTE：www.hsdk-pharmatech.cn
ADDRESS：Building H, No. 22 Tiansheng Road, Jiangbei New Area, Nanjing City, Jiangsu Province, China
客服7